Evidence map›Paper›PMID 27452732›Full record

ArticleScientific reports2016

A high-content image-based method for quantitatively studying context-dependent cell population dynamics.

Colleen M Garvey, Erin Spiller, Danika Lindsay, Chun-Te Chiang, Nathan C Choi, David B Agus, Parag Mallick, Jasmine Foo, Shannon M Mumenthaler

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Multiplex Hextuple Luciferase Assaying.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  18. Article
  19. Article
  20. Organoids in image-based phenotypic chemical screens.Experimental & molecular medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Colleen M GarveyLawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.
Erin SpillerLawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.
Danika LindsaySchool of Mathematics, University of Minnesota, Minneapolis, Minnesota, USA.
Chun-Te ChiangLawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.
Nathan C ChoiLawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.
David B AgusLawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.
Parag MallickDepartment of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Palo Alto, California, USA.
Jasmine FooSchool of Mathematics, University of Minnesota, Minneapolis, Minnesota, USA.
Shannon M MumenthalerLawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
TRANS-NETWORK PROJECTSU54CA143907 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AGUS, DAVID B · 2009 to 2013
$15.2M
The Cell-Of-Origin of Human CancersU54CA143798 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI MICHOR, FRANZISKA · 2009 to 2014
$11.2M
(PQB6)An Integrative Computational and Bioengineered Tissue Model of MetastasisR01CA180149 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AGUS, DAVID B, ATALA, ANTHONY · 2013 to 2016
$2.3M
NCI NIH HHS P30 CA014089NCI NIH HHS R01 CA180149NCI NIH HHS U54 CA143798NCI NIH HHS U54 CA143907
6 · The paper itself

Abstract

Tumor progression results from a complex interplay between cellular heterogeneity, treatment response, microenvironment and heterocellular interactions. Existing approaches to characterize this interplay suffer from an inability to distinguish between multiple cell types, often lack environmental context, and are unable to perform multiplex phenotypic profiling of cell populations. Here we present a high-throughput platform for characterizing, with single-cell resolution, the dynamic phenotypic responses (i.e. morphology changes, proliferation, apoptosis) of heterogeneous cell populations both during standard growth and in response to multiple, co-occurring selective pressures. The speed of this platform enables a thorough investigation of the impacts of diverse selective pressures including genetic alterations, therapeutic interventions, heterocellular components and microenvironmental factors. The platform has been applied to both 2D and 3D culture systems and readily distinguishes between (1) cytotoxic versus cytostatic cellular responses; and (2) changes in morphological features over time and in response to perturbation. These important features can directly influence tumor evolution and clinical outcome. Our image-based approach provides a deeper insight into the cellular dynamics and heterogeneity of tumors (or other complex systems), with reduced reagents and time, offering advantages over traditional biological assays.

Indexed as

Tumor MicroenvironmentCell Culture TechniquesCell Line, TumorHumansImage CytometryNeoplasms

Identifiers

PMID27452732
PMCPMC4958988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.